DanGer Shock: Microaxial Flow Pump versus Standard Care in Infarct-Related Cardiogenic Shock

The DanGer Shock trial assessed the efficacy of the Impella CP ventricular assist device in reducing mortality following myocardial infarction (MI). In this episode, Dr. Chadi Alraies discusses this important trial with the principal investigator, Professor Jacob Møller.
Learn more at www.cardiology-update.com
#cardiologyupdate #impella #pci #cardiology #DanGer